Literature DB >> 24809721

Study of motor asymmetry in ALS indicates an effect of limb dominance on onset and spread of weakness, and an important role for upper motor neurons.

Matthew S Devine1, Matthew C Kiernan, Susan Heggie, Pamela A McCombe, Robert D Henderson.   

Abstract

In amyotrophic lateral sclerosis (ALS), onset and spread of upper motor neuron (UMN) and lower motor neuron (LMN) dysfunction is typically asymmetric. Our aim was to investigate the relationship between limb dominance and the onset and spread of clinical UMN and LMN dysfunction in ALS. We studied 138 ALS subjects with unilateral and concordant limb dominance, from two tertiary centres. A questionnaire was used to determine the pattern of disease onset and spread. The clinical severity of UMN and LMN signs in each limb was quantified using a validated scoring system. Results showed that onset of weakness was more likely to occur in the dominant upper limb (p = 0.02). In subjects with initial weakness in a non-dominant limb, spread of weakness was more likely to be to the other limb on that side (p = 0.008). The relative distribution of upper limb UMN signs was affected by whether weakness first occurred on the dominant or non-dominant side (p = 0.03). These findings support limb dominance as a significant factor underlying onset and spread of ALS, with UMN processes playing an important role. The effect of limb dominance on the presentation of ALS may reflect underlying neuronal vulnerabilities, which become exposed by the disease.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; anterior horn cell disease; handedness; limb dominance; motor neuron disease

Mesh:

Year:  2014        PMID: 24809721     DOI: 10.3109/21678421.2014.906617

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  18 in total

1.  Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis.

Authors:  Neil G Simon; Michael Lee; Jong Seok Bae; Eneida Mioshi; Cindy S-Y Lin; Casey M Pfluger; Robert D Henderson; Steve Vucic; Michael Swash; David Burke; Matthew C Kiernan
Journal:  J Neurol       Date:  2015-04-07       Impact factor: 4.849

2.  Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis.

Authors:  Shunmoogum A Patten; Dina Aggad; Jose Martinez; Elsa Tremblay; Janet Petrillo; Gary Ab Armstrong; Alexandre La Fontaine; Claudia Maios; Meijiang Liao; Sorana Ciura; Xiao-Yan Wen; Victor Rafuse; Justin Ichida; Lorne Zinman; Jean-Pierre Julien; Edor Kabashi; Richard Robitaille; Lawrence Korngut; J Alexander Parker; Pierre Drapeau
Journal:  JCI Insight       Date:  2017-11-16

3.  Reduced retinal nerve fiber layer (RNFL) thickness in ALS patients: a window to disease progression.

Authors:  Mohammad Rohani; Alipasha Meysamie; Babak Zamani; Mohammad Mahdi Sowlat; Fahimeh Haji Akhoundi
Journal:  J Neurol       Date:  2018-04-30       Impact factor: 4.849

4.  Beyond fractional anisotropy in amyotrophic lateral sclerosis: the value of mean, axial, and radial diffusivity and its correlation with electrophysiological conductivity changes.

Authors:  Ana Filipa Geraldo; João Pereira; Pedro Nunes; Sofia Reimão; Rita Sousa; Miguel Castelo-Branco; Susana Pinto; Jorge Guedes Campos; Mamede de Carvalho
Journal:  Neuroradiology       Date:  2018-03-22       Impact factor: 2.804

Review 5.  Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.

Authors:  Steve Vucic; Matthew C Kiernan
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

Review 6.  Pathophysiological and diagnostic implications of cortical dysfunction in ALS.

Authors:  Nimeshan Geevasinga; Parvathi Menon; P Hande Özdinler; Matthew C Kiernan; Steve Vucic
Journal:  Nat Rev Neurol       Date:  2016-09-23       Impact factor: 42.937

7.  Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis.

Authors:  Matthew S Devine; Kerstin Pannek; Alan Coulthard; Pamela A McCombe; Stephen E Rose; Robert D Henderson
Journal:  Neuroimage Clin       Date:  2015-03-14       Impact factor: 4.881

8.  Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis.

Authors:  Beben Benyamin; Ji He; Qiongyi Zhao; Jacob Gratten; Fleur Garton; Paul J Leo; Zhijun Liu; Marie Mangelsdorf; Ammar Al-Chalabi; Lisa Anderson; Timothy J Butler; Lu Chen; Xiang-Ding Chen; Katie Cremin; Hong-Weng Deng; Matthew Devine; Janette Edson; Jennifer A Fifita; Sarah Furlong; Ying-Ying Han; Jessica Harris; Anjali K Henders; Rosalind L Jeffree; Zi-Bing Jin; Zhongshan Li; Ting Li; Mengmeng Li; Yong Lin; Xiaolu Liu; Mhairi Marshall; Emily P McCann; Bryan J Mowry; Shyuan T Ngo; Roger Pamphlett; Shu Ran; David C Reutens; Dominic B Rowe; Perminder Sachdev; Sonia Shah; Sharon Song; Li-Jun Tan; Lu Tang; Leonard H van den Berg; Wouter van Rheenen; Jan H Veldink; Robyn H Wallace; Lawrie Wheeler; Kelly L Williams; Jinyu Wu; Xin Wu; Jian Yang; Weihua Yue; Zong-Hong Zhang; Dai Zhang; Peter G Noakes; Ian P Blair; Robert D Henderson; Pamela A McCombe; Peter M Visscher; Huji Xu; Perry F Bartlett; Matthew A Brown; Naomi R Wray; Dongsheng Fan
Journal:  Nat Commun       Date:  2017-09-20       Impact factor: 14.919

9.  POEMS syndrome presentation with progressive weakness in upper and lower limbs: A case report.

Authors:  Chuang-Jie Cao; Cheng-Yun Dou; Ke-Hua Zhou; Jin-Bo Liu; Hong Lai
Journal:  Oncol Lett       Date:  2017-09-06       Impact factor: 2.967

10.  Serial MRI studies over 12 months using manual and atlas-based region of interest in patients with amyotrophic lateral sclerosis.

Authors:  Ashwag R Alruwaili; Kerstin Pannek; Robert D Henderson; Marcus Gray; Nyoman D Kurniawan; Pamela A McCombe
Journal:  BMC Med Imaging       Date:  2020-08-03       Impact factor: 1.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.